EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Frequency of naevus cells in lymph nodes of melanoma and breast cancer patients

Adele C Green, Piyushkumar A Mundra, Megan Grant, Richard Marais, Martin G Cook

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Adele C Green und 4 weiteren Autor:innen. Beteiligte Einrichtung: QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Molecular Oncology Group, CRUK Manchester Institute, University of Manche…. Hauptthemen laut MEDLINE: Breast Neoplasms, Melanoma, Nevus, Pigmented, Skin Neoplasms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRUK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: We aimed to study the frequency (prevalence) and histology of benign melanocytic naevus cells in regional lymph nodes in relation to age and sex and nodal location. MATERIAL AND METHODS: Histopathology reports of sentinel lymph node (SLN) biopsies from melanoma patients, 2002 - 2014, and from breast cancer patients, 2010- 2019, were obtained from records of a single hospital in England. All sections were similarly processed and examined. For standardisation, presence of naevus cells was assessed in a single node per patient: the first SLN biopsied (melanoma) or the node nearest the first SLN (breast cancer). RESULTS: Associations were tested using Fisher's exact test. Naevus cells were found in 10% (60/585) of melanoma patients' index SLNs. Frequency varied significantly by anatomic region: 13% in axillary to 0% cervical SLNs (p = 0.03), but not by sex or age. Within nodes, naevus cells were present in capsular or pericapsular tissue (93%), or trabeculae (7%). In breast cancer patients' index axillary nodes, 6% (11/196) contained naevus cells, all intracapsular. In the predominant 40-69 years age-group, prevalence was similar in breast cancer (7%) and female melanoma (9%) patients, but in those aged 70-100, prevalence was lower in breast cancer (2%) than in female melanoma (15%) patients (p = 0.05). CONCLUSIONS: Standard methods of assessment yielded no clear pattern of naevus cell frequency in lymph nodes by age or sex, but confirmed naevus cell location as mostly intracapsular.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMelanomaNevus, PigmentedSkin NeoplasmsHumansFemaleLymphatic MetastasisLymph NodesAxillaLymph Node Excision

Stichwörter der Autor:innen

Melanocytic naevus cellsSentinel lymph node biopsySentinel lymph nodes

Autor:innen und Institutionen

  • QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK. Electronic address: adele.green@qimrberghofer.ed…
  • Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK.
  • Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK; Histopathology, Royal Surrey Hospital, Guildford, UK; Division of Clinical Medicine, University of Surrey, Guildford, Surrey…

Förderung

  • CRUK

Zitieren

APA

Green, A. C., Mundra, P. A., Grant, M., Marais, R., & Cook, M. G. (2024). Frequency of naevus cells in lymph nodes of melanoma and breast cancer patients. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155106

Vancouver

Green AC, Mundra PA, Grant M, Marais R, Cook MG. Frequency of naevus cells in lymph nodes of melanoma and breast cancer patients. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155106

BibTeX
@article{Green2024,
  author = {Green, Adele C and Mundra, Piyushkumar A and Grant, Megan and Marais, Richard and Cook, Martin G},
  title = {Frequency of naevus cells in lymph nodes of melanoma and breast cancer patients},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155106}
}
Kostenlos starten →